XT
ORKA

XTX Topco’s Oruka Therapeutics ORKA Stock Holding History

XTX Topco’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85M Buy
40,506
+20,326
+101% +$1.35M 0.05% 530
2026
Q1 		$990K Buy
+20,180
New +$701K 0.02% 1426
2021
Q3 		– Sell
-904
Closed -$38K – 1116
2021
Q2 		$38K Buy
+904
New +$37.7K 0.01% 744

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

XTX Topco's ORKA Position: Q2 2026 in Review

XTX Topco increased its Oruka Therapeutics (ORKA) stake by 101% in Q2 2026, buying an estimated $1.35M and bringing the position to 40,506 shares worth $3.85M. The position accounts for 0.05% of the portfolio, ranked #530.

XTX Topco first reported a position in ORKA in Q2 2021 and has held it in 3 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • XTX Topco held 40,506 shares of Oruka Therapeutics worth $3.85M as of Q2 2026.
  • XTX Topco bought 20,326 Oruka Therapeutics shares in Q2 2026, an estimated $1.35M.
  • Oruka Therapeutics made up 0.05% of XTX Topco's portfolio in Q2 2026, its #530 holding.
  • XTX Topco first reported a position in Oruka Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.